Table 1 Background of the eligible patients

From: Ten-year follow-up results of a randomised controlled study comparing level-I vs level-III axillary lymph node dissection for primary breast cancer

 

Group-A (level-III), n =258

Group-B (level-I), n =256

Statistics

Age: mean±s.d.

50.6±10.1

51.6±10.6

NS

 Menopause (or >50 years)

127

131

NS

 Premenopause (50 years)

131

125

 

ER

   

 (+)

161

141

 

 (−)

75

95

 

 Unknown

22

20

 

T-factor

   

 Preoperative evaluation

   

T1

113

118

NS

T2

139

130

 

T3

6

8

 

 Postsurgical evaluation

   

Tis

12

7

NS

pT1

108

114

 

pT2

131

127

 

pT3

7

8

 

N-factor

   

 Preoperative evaluation (1987 UICC, 4th edition)

   

N0 (no palpable nodes)

152

149

NS

N1a (movable but not considered no growth)

74

66

 

N1b (movable considered to contain growth)

32

41

 

 Postsurgical evaluation (2002 UICC, 6th edition)

   

pN0

170

179

NS

pN1 (1–3 positive nodes)

62

49

 

pN2 (4–9 positive nodes)

10

19

 

pN3 (10 or more positive nodes)

16

9

 

 Preoperative stage (1987 UICC, 4th edition)

   

I

183

195

NS

II

54

60

 

III

21

1

 

 Postsurgical stage (2002 UICC, 6th edition)

   

0

12

7

NS

I

77

92

 

II

143

128

 

III

26

29

 

Surgery

   

 Mastectomy

96

95

NS

 Breast-conserving surgery

162

161

 
  1. ER=oestrogen receptor; NS=no significant differences; UICC=International Union Against Cancer.